c-erbb-2 gene amplification as a prognostic marker in human bladder cancer

By Miyamoto H.   Kubota Y.   Noguchi S.   Takase K.   Matsuzaki J.   Moriyama M.   Takebayashi S.   Kitamura H.   Hosaka M.  

Urology, Vol. 55, Iss. 5, 2000-05 ,pp. : 679-683

Elsevier

Access to resources Recommend Favorite

Pretreatment P53 nuclear overexpression as a prognostic marker in superficial bladder cancer treated with bacillus calmette-guerin (BCG)

By Saint F.   Le Frere Belda M.A.   Quitela R.   Gil Diez De Medina S.   Hoznek A.   Patard J.J.   Bellot J.   Popov Z.   Zafrani E.S.   Abbou C.C.   Chopin D.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 86-86

Elsevier

Access to resources Recommend Favorite

Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer

By Mungan N.A.   Vriesema J.L.J.   Thomas C.M.G.   Kiemeney L.A.L.M.   Witjes J.A.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 787-791

Elsevier

Access to resources Recommend Favorite

Molecular Aspects of Bladder Cancer - III. Prognostic Markers of Bladder Cancer

By Kausch I.   Bohle A.  

European Urology, Vol. 41, Iss. 1, 2002-01 ,pp. : 15-29

Elsevier

Access to resources Recommend Favorite

Antiprostasome antibodies are not an appropriate prognostic marker for prostate cancer

By Stewart Alistair   Delves George   Birch Brian   Cooper Alan   Lwaleed Bashir  

Scandinavian Journal of Urology and Nephrology, Vol. 43, Iss. 2, 2009-03 ,pp. : 104-108

Informa Healthcare

Access to resources Recommend Favorite